Investing.com - BioRestorative Therapies (NASDAQ: BRTX) reported first quarter EPS of $-0.510, in line with the analyst estimate of $-0.510. Revenue for the quarter came in at $30K versus the consensus estimate of $30K.
BioRestorative Therapies's stock price closed at $1.36. It is down -8.720% in the last 3 months and down -73.070% in the last 12 months.
BioRestorative Therapies saw positive EPS revisions and negative EPS revisions in the last 90 days. See BioRestorative Therapies's stock price’s past reactions to earnings here.
According to InvestingPro, BioRestorative Therapies's Financial Health score is "fair performance".
Check out BioRestorative Therapies's recent earnings performance, and BioRestorative Therapies's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar